Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review

TY Wong, A Ferreira, R Hughes, G Carter… - American journal of …, 2014 - Elsevier
Purpose To summarize the epidemiology of pathologic myopia and myopic choroidal
neovascularization (CNV) and their impact on vision. Design Systematic literature review of …

Myopia and orthokeratology for myopia control

P Cho, Q Tan - Clinical and experimental optometry, 2019 - Taylor & Francis
The prevalence of myopia in children is increasing worldwide and is viewed as a major
public health concern. This increase has driven interest in research into myopia prevention …

Long-term pattern of progression of myopic maculopathy: a natural history study

K Hayashi, K Ohno-Matsui, N Shimada, M Moriyama… - Ophthalmology, 2010 - Elsevier
OBJECTIVE: To investigate the long-term progression pattern of myopic maculopathy and to
determine the visual prognosis of each progression stage. DESIGN: Retrospective …

Choroidal neovascularization in pathological myopia

K Neelam, CMG Cheung, K Ohno-Matsui… - Progress in retinal and …, 2012 - Elsevier
Myopic choroidal neovascularization (CNV) is one of the leading causes of visual
impairment worldwide. The clinical and socioeconomic impact of myopic CNV in Asian …

Myopic choroidal neovascularization: a 10-year follow-up

T Yoshida, K Ohno-Matsui, K Yasuzumi, A Kojima… - Ophthalmology, 2003 - Elsevier
PURPOSE: To clarify the long-term visual outcome of choroidal neovascularization (CNV) in
eyes with high myopia in Asian patients. DESIGN: We reviewed the medical records of 25 …

Myopic choroidal neovascularisation: current concepts and update on clinical management

TY Wong, K Ohno-Matsui, N Leveziel… - British Journal of …, 2015 - bjo.bmj.com
Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia
and pathological myopia. Despite significant advances in understanding the epidemiology …

Myopic maculopathy: a review

R Silva - Ophthalmologica, 2012 - karger.com
Pathological myopia is a major cause of irreversible vision loss and is the fourth to ninth
most frequent cause of blindness in the world. Choroidal neovascularization (CNV) …

Bevacizumab (Avastin) for the treatment of ocular disease

JB Gunther, MM Altaweel - Survey of ophthalmology, 2009 - Elsevier
The use of intravitreal bevacizumab (Avastin) has greatly expanded since its introduction
into ophthalmic care 3 years ago. A PubMed search on 1 August 2008 revealed 51 ocular …

Complications of pathologic myopia

BJ Cho, JY Shin, HG Yu - Eye & contact lens, 2016 - journals.lww.com
Pathologic myopia (PM) is one of the leading causes of visual impairment worldwide. The
pathophysiology of PM is not fully understood, but the axial elongation of the eye followed by …

Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study

YF Shih, TC Ho, CK Hsiao, LLK Lin - British journal of ophthalmology, 2006 - bjo.bmj.com
Aim: To evaluate the visual outcomes for high myopic patients aged 40 years and older with
or without myopic maculopathy. Methods: 552 high myopic (spherical equivalent⩽− 6.0 D or …